Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillosis or mucormycosis. The objective of this study was to evaluate ISA levels in a real world setting in a mixed patient cohort including patients with non-malignant diseases and extracorporeal treatment...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Fungi (Basel)
Auteurs principaux: Zurl, Christoph, Waller, Maximilian, Schwameis, Franz, Muhr, Tina, Bauer, Norbert, Zollner-Schwetz, Ines, Valentin, Thomas, Meinitzer, Andreas, Ullrich, Elisabeth, Wunsch, Stefanie, Hoenigl, Martin, Grinschgl, Yvonne, Prattes, Juergen, Oulhaj, Abderrahim, Krause, Robert
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344482/
https://ncbi.nlm.nih.gov/pubmed/32580296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6020090
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires